Showing 1 - 10 of 13,752
Persistent link: https://www.econbiz.de/10011317852
Persistent link: https://www.econbiz.de/10010345456
Persistent link: https://www.econbiz.de/10010345585
pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …
Persistent link: https://www.econbiz.de/10012285099
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012103333
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012119750
consumers, we estimate that the annual compounded financial burden of import tariffs on pharmaceuticals and prevailing trade … the world's major low and middle income countries (BRICS-MINT countries). Studying the impact on final prices for … Nigeria (60,000 USD). For Brazil and India, tariffs on medicines increase their final price by up to 80 per cent of the …
Persistent link: https://www.econbiz.de/10011720622
Persistent link: https://www.econbiz.de/10013174826
Persistent link: https://www.econbiz.de/10014289935
Persistent link: https://www.econbiz.de/10003977328